尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Fontenot Jason D., Vice-Président, Directeur Scientifique. Insider active across 1 company, notably Sangamo Therapeutics, INC. Aggregated, 6 disclosures have been recorded. History available since 25 February 2022. The latest transaction was disclosed on 25 November 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Fontenot Jason D. is Vice-President, Chief Scientific Officer. He has 6 filings in total, and across the 6 most recent filings held, the modal transaction nature is Tax withholding, with a period from 2022-03-01 to 2023-11-28 and reported buy and sell amounts of EUR 0.